Structure

Physi-Chem Properties

Molecular Weight:  484.21
Volume:  484.632
LogP:  3.822
LogD:  2.514
LogS:  -4.201
# Rotatable Bonds:  2
TPSA:  119.36
# H-Bond Aceptor:  8
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.582
Synthetic Accessibility Score:  5.09
Fsp3:  0.593
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.296
MDCK Permeability:  3.095968713751063e-05
Pgp-inhibitor:  0.973
Pgp-substrate:  0.028
Human Intestinal Absorption (HIA):  0.05
20% Bioavailability (F20%):  0.161
30% Bioavailability (F30%):  0.479

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.696
Plasma Protein Binding (PPB):  82.52892303466797%
Volume Distribution (VD):  0.959
Pgp-substrate:  15.487676620483398%

ADMET: Metabolism

CYP1A2-inhibitor:  0.087
CYP1A2-substrate:  0.245
CYP2C19-inhibitor:  0.039
CYP2C19-substrate:  0.273
CYP2C9-inhibitor:  0.448
CYP2C9-substrate:  0.283
CYP2D6-inhibitor:  0.595
CYP2D6-substrate:  0.074
CYP3A4-inhibitor:  0.683
CYP3A4-substrate:  0.469

ADMET: Excretion

Clearance (CL):  3.543
Half-life (T1/2):  0.252

ADMET: Toxicity

hERG Blockers:  0.83
Human Hepatotoxicity (H-HT):  0.866
Drug-inuced Liver Injury (DILI):  0.249
AMES Toxicity:  0.041
Rat Oral Acute Toxicity:  0.95
Maximum Recommended Daily Dose:  0.975
Skin Sensitization:  0.345
Carcinogencity:  0.735
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.961

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC294149

Natural Product ID:  NPC294149
Common Name*:   DYQKBALSPZQWQD-FWEFFTEASA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  DYQKBALSPZQWQD-FWEFFTEASA-N
Standard InCHI:  InChI=1S/C27H32O8/c1-12-23(34-13(2)28)21-14-9-18-26(5)8-7-19(30)25(3,4)17(26)11-20(31)27(18,6)35-16(14)10-15(29)22(21)24(32)33-12/h7-8,10,12,17-18,20,23,29,31H,9,11H2,1-6H3/t12-,17+,18+,20+,23+,26+,27-/m1/s1
SMILES:  CC(=O)O[C@H]1[C@@H](C)OC(=O)c2c1c1C[C@@H]3[C@](Oc1cc2O)(C)[C@@H](O)C[C@@H]1[C@]3(C)C=CC(=O)C1(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3581316
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001538] Diterpene lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32870 penicillium funiculosum gwt2-24 Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[26046820]
NPO33271 penicillium verruculosum Species Aspergillaceae Eukaryota n.a. Indonesian n.a. PMID[26115570]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT116 Cell Line HL-60 Homo sapiens IC50 > 50000.0 nM PMID[456163]
NPT111 Cell Line K562 Homo sapiens IC50 > 50000.0 nM PMID[456163]
NPT165 Cell Line HeLa Homo sapiens IC50 > 50000.0 nM PMID[456163]
NPT81 Cell Line A549 Homo sapiens IC50 > 50000.0 nM PMID[456163]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 600.0 ug.mL-1 PMID[456163]
NPT19 Organism Escherichia coli Escherichia coli MIC > 600.0 ug.mL-1 PMID[456163]
NPT1453 Organism Influenza A virus (A/PR/8/34(H1N1)) Influenza A virus (A/Puerto Rico/8/1934(H1N1)) IC50 = 55000.0 nM PMID[456163]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC294149 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9877 High Similarity NPC472620
0.9753 High Similarity NPC472619
0.9571 High Similarity NPC472622
0.9509 High Similarity NPC472621
0.9444 High Similarity NPC473022
0.9222 High Similarity NPC251144
0.9222 High Similarity NPC241387
0.9202 High Similarity NPC472618
0.9118 High Similarity NPC312630
0.9118 High Similarity NPC324220
0.9085 High Similarity NPC472055
0.907 High Similarity NPC475161
0.907 High Similarity NPC477860
0.9048 High Similarity NPC207574
0.9048 High Similarity NPC291795
0.9048 High Similarity NPC102810
0.9048 High Similarity NPC297195
0.9042 High Similarity NPC178173
0.9042 High Similarity NPC469394
0.9024 High Similarity NPC472617
0.9024 High Similarity NPC470339
0.9006 High Similarity NPC469345
0.8994 High Similarity NPC241874
0.896 High Similarity NPC208069
0.8947 High Similarity NPC232412
0.8947 High Similarity NPC86809
0.8947 High Similarity NPC98667
0.8929 High Similarity NPC207575
0.8929 High Similarity NPC13481
0.8929 High Similarity NPC125465
0.8916 High Similarity NPC3629
0.8914 High Similarity NPC197972
0.8902 High Similarity NPC164427
0.8895 High Similarity NPC46958
0.8895 High Similarity NPC475246
0.8889 High Similarity NPC469393
0.8889 High Similarity NPC154986
0.8882 High Similarity NPC313717
0.8882 High Similarity NPC315306
0.8882 High Similarity NPC103307
0.8876 High Similarity NPC474024
0.8876 High Similarity NPC225419
0.8869 High Similarity NPC475979
0.8869 High Similarity NPC293319
0.8862 High Similarity NPC473961
0.8855 High Similarity NPC471976
0.8844 High Similarity NPC477682
0.8844 High Similarity NPC477683
0.8841 High Similarity NPC477958
0.8837 High Similarity NPC3718
0.8837 High Similarity NPC63105
0.8837 High Similarity NPC68381
0.8834 High Similarity NPC470340
0.883 High Similarity NPC212038
0.883 High Similarity NPC262580
0.883 High Similarity NPC289396
0.883 High Similarity NPC271848
0.883 High Similarity NPC81332
0.8802 High Similarity NPC97812
0.8802 High Similarity NPC117985
0.88 High Similarity NPC475148
0.88 High Similarity NPC475656
0.8795 High Similarity NPC4950
0.8795 High Similarity NPC239118
0.8793 High Similarity NPC473785
0.8793 High Similarity NPC245059
0.8793 High Similarity NPC473607
0.8793 High Similarity NPC84494
0.8788 High Similarity NPC472050
0.878 High Similarity NPC192189
0.878 High Similarity NPC472799
0.8779 High Similarity NPC213052
0.8773 High Similarity NPC470675
0.8773 High Similarity NPC473131
0.8773 High Similarity NPC70016
0.8773 High Similarity NPC215921
0.8772 High Similarity NPC298778
0.8772 High Similarity NPC477670
0.8772 High Similarity NPC313304
0.8772 High Similarity NPC74559
0.8772 High Similarity NPC193698
0.8765 High Similarity NPC218226
0.8765 High Similarity NPC6588
0.8765 High Similarity NPC477154
0.8765 High Similarity NPC117854
0.8757 High Similarity NPC294722
0.8757 High Similarity NPC471788
0.8757 High Similarity NPC105591
0.875 High Similarity NPC474034
0.875 High Similarity NPC474033
0.875 High Similarity NPC220912
0.875 High Similarity NPC472964
0.875 High Similarity NPC472402
0.8743 High Similarity NPC321399
0.8743 High Similarity NPC470448
0.8743 High Similarity NPC164047
0.8743 High Similarity NPC470453
0.8743 High Similarity NPC470452
0.8736 High Similarity NPC470334
0.8736 High Similarity NPC476199
0.8736 High Similarity NPC476210
0.8735 High Similarity NPC158542
0.8728 High Similarity NPC474345
0.8728 High Similarity NPC162248
0.8727 High Similarity NPC68727
0.8727 High Similarity NPC477671
0.8727 High Similarity NPC477687
0.8727 High Similarity NPC175192
0.8721 High Similarity NPC271385
0.8721 High Similarity NPC5029
0.8721 High Similarity NPC118128
0.8721 High Similarity NPC111536
0.8721 High Similarity NPC30432
0.8721 High Similarity NPC76128
0.872 High Similarity NPC470338
0.872 High Similarity NPC256141
0.872 High Similarity NPC167903
0.872 High Similarity NPC113608
0.872 High Similarity NPC268992
0.872 High Similarity NPC475790
0.872 High Similarity NPC51824
0.872 High Similarity NPC180944
0.872 High Similarity NPC470337
0.8715 High Similarity NPC264302
0.8713 High Similarity NPC188079
0.8713 High Similarity NPC54903
0.8713 High Similarity NPC288813
0.8713 High Similarity NPC177480
0.8713 High Similarity NPC286074
0.8713 High Similarity NPC222455
0.8713 High Similarity NPC326877
0.8706 High Similarity NPC120593
0.8706 High Similarity NPC43319
0.8706 High Similarity NPC272502
0.8706 High Similarity NPC471213
0.8701 High Similarity NPC221140
0.8701 High Similarity NPC473686
0.8701 High Similarity NPC229817
0.8701 High Similarity NPC475220
0.8701 High Similarity NPC87583
0.8701 High Similarity NPC475352
0.8698 High Similarity NPC186686
0.8698 High Similarity NPC205265
0.8698 High Similarity NPC472281
0.8698 High Similarity NPC469395
0.8698 High Similarity NPC12461
0.8698 High Similarity NPC476295
0.8693 High Similarity NPC473717
0.8693 High Similarity NPC475662
0.8693 High Similarity NPC293227
0.8693 High Similarity NPC473631
0.869 High Similarity NPC471210
0.869 High Similarity NPC134783
0.869 High Similarity NPC92589
0.869 High Similarity NPC57715
0.869 High Similarity NPC228383
0.869 High Similarity NPC471211
0.869 High Similarity NPC471212
0.869 High Similarity NPC472632
0.869 High Similarity NPC472634
0.8686 High Similarity NPC299149
0.8686 High Similarity NPC277710
0.8686 High Similarity NPC153578
0.8686 High Similarity NPC114257
0.8686 High Similarity NPC473729
0.8683 High Similarity NPC474373
0.8683 High Similarity NPC210459
0.8683 High Similarity NPC186113
0.8683 High Similarity NPC473990
0.8678 High Similarity NPC475233
0.8678 High Similarity NPC478050
0.8675 High Similarity NPC471787
0.8675 High Similarity NPC4547
0.8675 High Similarity NPC146636
0.8675 High Similarity NPC20530
0.8675 High Similarity NPC78492
0.8675 High Similarity NPC215917
0.8675 High Similarity NPC10754
0.8675 High Similarity NPC208152
0.8675 High Similarity NPC477674
0.8671 High Similarity NPC476139
0.8671 High Similarity NPC476152
0.8671 High Similarity NPC471969
0.8671 High Similarity NPC472054
0.8671 High Similarity NPC476311
0.8671 High Similarity NPC475080
0.8667 High Similarity NPC155686
0.8667 High Similarity NPC223701
0.8667 High Similarity NPC326592
0.8667 High Similarity NPC469405
0.8667 High Similarity NPC112701
0.8667 High Similarity NPC7989
0.8667 High Similarity NPC472583
0.8667 High Similarity NPC109594
0.8663 High Similarity NPC472276
0.8659 High Similarity NPC263384
0.8659 High Similarity NPC471676
0.8659 High Similarity NPC474023
0.8659 High Similarity NPC471677
0.8659 High Similarity NPC474021

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC294149 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8667 High Similarity NPD7819 Suspended
0.8623 High Similarity NPD7075 Discontinued
0.858 High Similarity NPD6959 Discontinued
0.8488 Intermediate Similarity NPD7473 Discontinued
0.8485 Intermediate Similarity NPD4380 Phase 2
0.8448 Intermediate Similarity NPD7074 Phase 3
0.8443 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.843 Intermediate Similarity NPD6166 Phase 2
0.843 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.843 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8391 Intermediate Similarity NPD7054 Approved
0.8391 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8391 Intermediate Similarity NPD5844 Phase 1
0.8383 Intermediate Similarity NPD6801 Discontinued
0.8362 Intermediate Similarity NPD8312 Approved
0.8362 Intermediate Similarity NPD8313 Approved
0.8343 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8343 Intermediate Similarity NPD7472 Approved
0.8343 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8314 Intermediate Similarity NPD6232 Discontinued
0.8304 Intermediate Similarity NPD5494 Approved
0.8294 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8284 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8274 Intermediate Similarity NPD1934 Approved
0.8249 Intermediate Similarity NPD7251 Discontinued
0.8225 Intermediate Similarity NPD1465 Phase 2
0.8222 Intermediate Similarity NPD8150 Discontinued
0.8214 Intermediate Similarity NPD7411 Suspended
0.8202 Intermediate Similarity NPD7808 Phase 3
0.8192 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8192 Intermediate Similarity NPD6797 Phase 2
0.8155 Intermediate Similarity NPD6599 Discontinued
0.8146 Intermediate Similarity NPD6559 Discontinued
0.8125 Intermediate Similarity NPD3818 Discontinued
0.8122 Intermediate Similarity NPD8434 Phase 2
0.8114 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8101 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD2532 Approved
0.8072 Intermediate Similarity NPD2534 Approved
0.8072 Intermediate Similarity NPD2533 Approved
0.807 Intermediate Similarity NPD3817 Phase 2
0.807 Intermediate Similarity NPD5402 Approved
0.8049 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.8033 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD2801 Approved
0.7979 Intermediate Similarity NPD8151 Discontinued
0.7977 Intermediate Similarity NPD3749 Approved
0.7964 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD4628 Phase 3
0.7939 Intermediate Similarity NPD3750 Approved
0.7927 Intermediate Similarity NPD1549 Phase 2
0.7927 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7921 Intermediate Similarity NPD7228 Approved
0.7921 Intermediate Similarity NPD3751 Discontinued
0.7919 Intermediate Similarity NPD3882 Suspended
0.7919 Intermediate Similarity NPD7768 Phase 2
0.7906 Intermediate Similarity NPD7435 Discontinued
0.7904 Intermediate Similarity NPD6799 Approved
0.7882 Intermediate Similarity NPD3226 Approved
0.7879 Intermediate Similarity NPD2800 Approved
0.787 Intermediate Similarity NPD5403 Approved
0.7866 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7866 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7806 Intermediate Similarity NPD7783 Phase 2
0.7806 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD6100 Approved
0.7805 Intermediate Similarity NPD6099 Approved
0.7798 Intermediate Similarity NPD1511 Approved
0.7772 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD2346 Discontinued
0.7751 Intermediate Similarity NPD5401 Approved
0.7749 Intermediate Similarity NPD6781 Approved
0.7749 Intermediate Similarity NPD6780 Approved
0.7749 Intermediate Similarity NPD6779 Approved
0.7749 Intermediate Similarity NPD6778 Approved
0.7749 Intermediate Similarity NPD6776 Approved
0.7749 Intermediate Similarity NPD6782 Approved
0.7749 Intermediate Similarity NPD6777 Approved
0.773 Intermediate Similarity NPD6651 Approved
0.772 Intermediate Similarity NPD7697 Approved
0.772 Intermediate Similarity NPD7696 Phase 3
0.772 Intermediate Similarity NPD7698 Approved
0.7706 Intermediate Similarity NPD1512 Approved
0.7697 Intermediate Similarity NPD3787 Discontinued
0.7697 Intermediate Similarity NPD2796 Approved
0.768 Intermediate Similarity NPD8320 Phase 1
0.768 Intermediate Similarity NPD8319 Approved
0.7674 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD7458 Discontinued
0.7665 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD7874 Approved
0.7653 Intermediate Similarity NPD7701 Phase 2
0.7647 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD37 Approved
0.7636 Intermediate Similarity NPD3748 Approved
0.7636 Intermediate Similarity NPD1510 Phase 2
0.7627 Intermediate Similarity NPD6234 Discontinued
0.7614 Intermediate Similarity NPD4966 Approved
0.7614 Intermediate Similarity NPD4967 Phase 2
0.7614 Intermediate Similarity NPD4965 Approved
0.7598 Intermediate Similarity NPD5710 Approved
0.7598 Intermediate Similarity NPD5711 Approved
0.759 Intermediate Similarity NPD7870 Phase 2
0.759 Intermediate Similarity NPD2935 Discontinued
0.759 Intermediate Similarity NPD7871 Phase 2
0.7582 Intermediate Similarity NPD7286 Phase 2
0.7577 Intermediate Similarity NPD6823 Phase 2
0.756 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD920 Approved
0.7554 Intermediate Similarity NPD7240 Approved
0.7552 Intermediate Similarity NPD7699 Phase 2
0.7552 Intermediate Similarity NPD7700 Phase 2
0.7542 Intermediate Similarity NPD7199 Phase 2
0.7542 Intermediate Similarity NPD8127 Discontinued
0.7538 Intermediate Similarity NPD7801 Approved
0.753 Intermediate Similarity NPD2799 Discontinued
0.7515 Intermediate Similarity NPD1607 Approved
0.75 Intermediate Similarity NPD1240 Approved
0.75 Intermediate Similarity NPD6273 Approved
0.75 Intermediate Similarity NPD5953 Discontinued
0.75 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD8455 Phase 2
0.7487 Intermediate Similarity NPD6534 Approved
0.7487 Intermediate Similarity NPD6535 Approved
0.7485 Intermediate Similarity NPD7390 Discontinued
0.7485 Intermediate Similarity NPD1551 Phase 2
0.7474 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7459 Intermediate Similarity NPD7685 Pre-registration
0.743 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD919 Approved
0.7425 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD8166 Discontinued
0.7412 Intermediate Similarity NPD7003 Approved
0.7412 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD7229 Phase 3
0.7401 Intermediate Similarity NPD5761 Phase 2
0.7401 Intermediate Similarity NPD5760 Phase 2
0.7378 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD230 Phase 1
0.7349 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD5124 Phase 1
0.7341 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD7584 Approved
0.7333 Intermediate Similarity NPD8285 Discontinued
0.7295 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD2313 Discontinued
0.7268 Intermediate Similarity NPD3926 Phase 2
0.7267 Intermediate Similarity NPD6190 Approved
0.7257 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7253 Intermediate Similarity NPD1247 Approved
0.7251 Intermediate Similarity NPD1243 Approved
0.7246 Intermediate Similarity NPD447 Suspended
0.7234 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD4360 Phase 2
0.7216 Intermediate Similarity NPD4363 Phase 3
0.7216 Intermediate Similarity NPD1653 Approved
0.7186 Intermediate Similarity NPD1613 Approved
0.7186 Intermediate Similarity NPD943 Approved
0.7186 Intermediate Similarity NPD4060 Phase 1
0.7186 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD5408 Approved
0.7176 Intermediate Similarity NPD5406 Approved
0.7176 Intermediate Similarity NPD5404 Approved
0.7176 Intermediate Similarity NPD5405 Approved
0.7169 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD6213 Phase 3
0.7165 Intermediate Similarity NPD6212 Phase 3
0.716 Intermediate Similarity NPD7097 Phase 1
0.7157 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6832 Phase 2
0.7143 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7129 Intermediate Similarity NPD7585 Approved
0.7129 Intermediate Similarity NPD7907 Approved
0.7118 Intermediate Similarity NPD7033 Discontinued
0.7118 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD4111 Phase 1
0.7115 Intermediate Similarity NPD4665 Approved
0.7108 Intermediate Similarity NPD4625 Phase 3
0.7101 Intermediate Similarity NPD8404 Phase 2
0.71 Intermediate Similarity NPD7497 Discontinued
0.71 Intermediate Similarity NPD7680 Approved
0.7098 Intermediate Similarity NPD4287 Approved
0.709 Intermediate Similarity NPD6764 Approved
0.709 Intermediate Similarity NPD8368 Discontinued
0.709 Intermediate Similarity NPD6765 Approved
0.7087 Intermediate Similarity NPD7930 Approved
0.7079 Intermediate Similarity NPD7583 Approved
0.7072 Intermediate Similarity NPD4288 Approved
0.7072 Intermediate Similarity NPD5353 Approved
0.7059 Intermediate Similarity NPD7177 Discontinued
0.7052 Intermediate Similarity NPD6674 Discontinued
0.7048 Intermediate Similarity NPD8366 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data